News

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
Change of Venue Doesn't Impede a Request to Change Judges, State Appellate Court Said
After an underlying case was transferred from Miller County to Greene County in Missouri, a Greene County Circuit judge ...
Truthout3d
A Majority of Americans Want Congress to Block Trump’s Tariffs — Poll
A new poll shows that a majority of Americans oppose tariffs imposed by President Donald Trump and want Congress to take ...
Truthout3d
Democrats Shift Towards Limiting Stock Trading by Members of Congress
Democratic leadership also appears to be opening up to the idea of at least some restrictions on stock trading among federal policymakers. In an interview with MSNBC host Jen Psaki on Monday night, ...
Don’t Let An Anchor Drag Down The Defense at Trial
The authors write "Anchoring” is a cognitive bias where an initial number sets a reference point (the “anchor”) that ...